ESHO 2018 / heckel medizintechnik gmbh

Successful participation at ESHO meeting 2018 in Berlin.

Successful participation at ESHO meeting 2018 in Berlin.

heckel was "Silver Sponsor" of the 32nd Annual Meeting of the European Society for Hyperthermic Oncology (ESHO) 16.-19. Mai 2018 in Berlin.

In the clinical session Dr. Markus Notter, Lindenhofspital Bern/Switzerland, reported the updated results of 140 patients with pre-irradiated locally recurrent breast cancer (LRBC), treated by thermography-controlled wIRA superficial hyperthermia in combination with hypofractionated radiotherapy and suggested a new staging of size of LRBC.

The congress abstracts are available by:

These e-posters are related to heckel whole-body hyperthermia:

P 12
Wey S: 14 years fever-range whole body hyperthermia in adjuvant recurrence prophylaxis of breast cancer


P 35
Kleef R et al: Exogenous and endogenous hyperthermia combining lowdose checkpoint inhibitors with interleukin-2 (IL-2) and fever range whole body and local regional hyperthermia in stage IV cancer


P 38
Pinto J et al: Fever-range whole body hyperthermia with concomitant capecitabine in third line therapy for BRCA mutated metastatic breast cancer


P 43
Douwes F: The successful antibiotic augmented thermal eradication of chronic lyme disease


Print Email

heckel medizintechnik GmbH

Olgastrasse 25
73728 Esslingen

Tel: ++49 (0)711 - 128989 - 0
Fax: ++49 (0)711 - 128989 - 20






Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
data privacy statement Accept Decline